Two Gestational Guides Guidelines for Professionals and Patients  Two guides released by HHS’ Agency for Healthcare Research and Quality can help women with gestational diabetes and their doctors make informed decisions about different treatments for the condition.   Two Gestational Guides

Another new category of anti-diabetic medicines called SGLT-2 inhibitors have been found to reduce blood sugars without the use of insulin. These drugs make the kidneys spill sugar into the urine. This has two potentially beneficial effects. First, it lowers blood sugar levels by helping the body eliminate high sugars …

There is good evidence that the insulin-producing cells of the body are damaged and destroyed by inflammation in Type 2 diabetes. That puts it in a similar category with other inflammatory diseases such as rheumatoid arthritis and gout. One new agent being investigated is called interleukin-2 (IL-2) beta receptor antagonist. …

Meal Replacements Work to Increase Weight Loss. Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study. The study assessed weight outcomes, behavioral data and side effects for obese patients enrolled in an intensive behavioral weight loss program. Patients either …

Mental Health Disorders Linked to Diabetes Risk. Common mental health disorders such as depression and anxiety are strongly linked to an increased risk for obesity and diabetes — an association that grows stronger as individuals age, new research suggests. The authors report that the excess risk for obesity in the …

In a recent published study, it was found that when insulin was the first treatment choice over multiple oral drugs, there was less weight gain and fewer hypoglycemic reactions. Give your patients a choice!  

Insulin resistance and impaired glucose tolerance developed in healthy volunteers after just two weeks of a shortened sleep schedule in a randomized crossover trial.  

The US Food and Drug Administration (FDA) has notified healthcare professionals of the potential for falsely elevated blood glucose results with the use of glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) glucose test strips in patients receiving products containing certain nonglucose sugars.  

Two new guides released last week by HHS’ Agency for Healthcare Research and Quality can help women with gestational diabetes and their doctors make informed decisions about different treatments for the condition.  

Excess urinary albumin excretion emerged as a significant predictor of mortality and other poor outcomes in a post analysis of about 2,300 heart-failure patients in a major clinical study.